Evidence map›Paper›PMID 36330824›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021.

Kylie E C Ainslie, Jantien A Backer, Pieter T de Boer, Albert Jan van Hoek, Don Klinkenberg, Hester Korthals Altes, Ka Yin Leung, Hester de Melker, Fuminari Miura, Jacco Wallinga

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Projecting COVID-19 intensive care admissions for policy advice, the Netherlands, February 2020 to January 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  3. Article
  4. Wastewater-based reproduction numbers and projections of COVID-19 cases in three areas in Japan, November 2021 to December 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Kylie E C AinslieMRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, United Kingdom.
Jantien A BackerCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Pieter T de BoerCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Albert Jan van HoekCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Don KlinkenbergCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Hester Korthals AltesCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Ka Yin LeungCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Hester de MelkerCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Fuminari MiuraCenter for Marine Environmental Studies (CMES), Ehime University, Ehime, Japan.
Jacco WallingaDepartment of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
National Institute for Public Health and the Environment · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundSince the roll-out of COVID-19 vaccines in late 2020 and throughout 2021, European governments have relied on mathematical modelling to inform policy decisions about COVID-19 vaccination.AimWe present a scenario-based modelling analysis in the Netherlands during summer 2021, to inform whether to extend vaccination to adolescents (12-17-year-olds) and children (5-11-year-olds).MethodsWe developed a deterministic, age-structured susceptible-exposed-infectious-recovered (SEIR) model and compared modelled incidences of infections, hospital and intensive care admissions, and deaths per 100,000 people across vaccination scenarios, before the emergence of the Omicron variant.ResultsOur model projections showed that, on average, upon the release of all non-pharmaceutical control measures on 1 November 2021, a large COVID-19 wave may occur in winter 2021/22, followed by a smaller, second wave in spring 2022, regardless of the vaccination scenario. The model projected reductions in infections/severe disease outcomes when vaccination was extended to adolescents and further reductions when vaccination was extended to all people over 5 years-old. When examining projected disease outcomes by age group, individuals benefitting most from extending vaccination were adolescents and children themselves. We also observed reductions in disease outcomes in older age groups, particularly of parent age (30-49 years), when children and adolescents were vaccinated, suggesting some prevention of onward transmission from younger to older age groups.ConclusionsWhile our scenarios could not anticipate the emergence/consequences of SARS-CoV-2 Omicron variant, we illustrate how our approach can assist decision making. This could be useful when considering to provide booster doses or intervening against future infection waves.

Indexed as

COVID-19SARS-CoV-2AdolescentAdultAgedChildChild, PreschoolCOVID-19 VaccinesHumansMiddle AgedNetherlandsVaccinationCOVID-19 Vaccineschildren and adolescentsCOVID-19 vaccinationdisease outcomeshealth policySARS-CoV-2scenario modelling

Identifiers

PMID36330824
PMCPMC9635025
OpenAlexW4308336962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.